Showing items 1–100
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF
Application WO-2024052336-A1
World Intellectual Property Organisation (WIPO)
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF
Application EP-4331602-A1
European Patent Office
RNA vaccine against SARS-CoV-2 variants
Grant US-11918643-B2
United States of America
ANTIVIRAL COMPOUND
Application WO-2024033372-A1
World Intellectual Property Organisation (WIPO)
Active low molecular weight variants of angiotensin converting enzyme 2 (ACE2)
Grant US-11891638-B2
United States of America
ANTIBODIES AGAINST SARS-COV-2
Application EP-4245373-A3
European Patent Office
Antibody cocktail against SARS-CoV-2 spike protein
Grant US-11834493-B2
United States of America
PTP1B INHIBITORS FOR TREATING LUNG INJURY
Application WO-2023230593-A1
World Intellectual Property Organisation (WIPO)
Single domain antibody binding to SARS-CoV-2 spike protein
Application KR-20230150184-A
Republic of Korea
Lipid nanoparticles for delivering mRNA vaccines
Grant US-11771652-B2
United States of America
Lipid nanoparticles for delivering mRNA vaccines
Grant US-11771653-B2
United States of America
INTRANASAL FORMULATIONS AND ANTI-SARS-COV-2-SPIKE PROTEIN ANTIBODIES
Application WO-2023155902-A1
World Intellectual Property Organisation (WIPO)
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments
Grant US-11732030-B2
United States of America
A LIVE ATTENUATED SARS-COV-2 AND A VACCINE MADE THEREOF
Application WO-2023138770-A1
World Intellectual Property Organisation (WIPO)
Neutralizing antibody immunoassays
Grant US-11693011-B2
United States of America
CpG-adjuvanted SARS-CoV-2 virus vaccine
Grant US-11684669-B2
United States of America
ANTIVIRAL COMPOUNDS
Application WO-2023104882-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES SPECIFIC TO CEACAM1
Application WO-2023105528-A1
World Intellectual Property Organisation (WIPO)
EXPRESSION OF THE SPIKE S GLYCOPROTEIN OF SARS-COV-2 FROM AVIAN PARAMYXOVIRUS TYPE 3 (APMV3…
Application WO-2023091988-A1
World Intellectual Property Organisation (WIPO)
Binding agent with enhanced affinity for the prevention and treatment of sarbecovirus-relat…
Application FR-3128713-A1
France
BINDING AGENT WITH IMPROVED AFFINITY FOR THE PREVENTION AND TREATMENT OF SARBECOVIRUS-RELAT…
Application WO-2023073328-A1
World Intellectual Property Organisation (WIPO)
NEW ISOLATED BAT SARS-COV ABLE TO INFECT HUMAN CELLS AND HARBORING RECEPTOR-BINDING…
Application WO-2023031315-A2
World Intellectual Property Organisation (WIPO)
Coronavirus vaccine
Grant US-11596686-B2
United States of America
Coronavirus vaccine
Grant US-11576966-B2
United States of America
Virus-like particles for preventing the spreading and lowering the infection rate of…
Grant US-11564892-B2
United States of America
A PHARMACEUTICAL COMPOSITION COMPRISING BAY 86-5277 AND SALTS THEREOF FOR USE IN THE…
Application WO-2023280828-A1
World Intellectual Property Organisation (WIPO)
A PHARMACEUTICAL COMPOSITION COMPRISING BAY 86-5277 AND SALTS THEREOF FOR USE IN THE…
Application EP-4115885-A1
European Patent Office
TREATMENT OF ACE2-MEDIATED VIRAL INFECTION
Application WO-2022248738-A1
World Intellectual Property Organisation (WIPO)
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2…
Grant US-11498944-B2
United States of America
MATURE ADRENOMEDULLIN FOR THERAPY STRATIFICATION OF CORTICOSTEROIDS IN CRITICALLY ILL…
Application WO-2022234111-A1
World Intellectual Property Organisation (WIPO)
Antibodies against SARS-CoV-2 and methods of using the same
Grant US-11479599-B2
United States of America
NOVEL UNIVERSAL VACCINE PRESENTING SYSTEM
Application WO-2022218997-A1
World Intellectual Property Organisation (WIPO)
Genetically encoded system for constructing and detecting biologically active agents
Grant US-11472847-B2
United States of America
ANTI VIRAL THERAPY
Application WO-2022195296-A1
World Intellectual Property Organisation (WIPO)
Compositions for preventing or treating viral and other microbial infections
Grant US-11440952-B2
United States of America
Temperature-based transient delivery of nucleic acids and proteins to cells and tissues
Grant US-11421248-B2
United States of America
A VIRUS-ENCODED MICRORNA FOR USE IN THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF SARS-COV-2…
Application WO-2022171899-A1
World Intellectual Property Organisation (WIPO)
Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated Salmonella…
Grant US-11406702-B1
United States of America
FOLD PROMOTERS AND THEIR USE FOR THE PRODUCTION AND STABILIZATION OF POLYPEPTIDES
Application WO-2022162165-A2
World Intellectual Property Organisation (WIPO)
FOLD PROMOTERS AND THEIR USE FOR THE PRODUCTION AND STABILIZATION OF POLYPEPTIDES
Application EP-4035677-A1
European Patent Office
Immunomodulatory anti-CD73 antibodies and uses thereof
Application KR-20220107196-A
Republic of Korea
VARIANT STRAIN-BASED CORONAVIRUS VACCINES
Application WO-2022155524-A1
World Intellectual Property Organisation (WIPO)
VARIANT STRAIN-BASED CORONAVIRUS VACCINES
Application WO-2022155530-A1
World Intellectual Property Organisation (WIPO)
ENGINEERING, PRODUCTION AND CHARACTERIZATION OF PLANT PRODUCED NUCLEOCAPSID AND SPIKE…
Application EP-4029569-A1
European Patent Office
PROTEASE INHIBITORS, PREPARATION, AND USES THEREOF
Application EP-4026830-A1
European Patent Office
Compositions and methods for preventing and treating coronavirus infection—SARS-CoV-2…
Grant US-11384122-B2
United States of America
Immunogenic and vaccine compositions against SARS-CoV-2
Grant US-11376320-B2
United States of America
NUCLEIC ACID SEQUENCE EXPRESSING SARS-COV-2 VIRUS ANTIGEN PEPTIDE AND USE THEREOF
Application EP-3805392-A4
European Patent Office
NEUTRALIZING ANTIBODY IMMUNOASSAYS
Application WO-2022132625-A1
World Intellectual Property Organisation (WIPO)
Anti-SARS-COV-2 antibodies and uses thereof
Grant US-11365239-B2
United States of America
ANTIBODIES THAT BIND TO MULTIPLE BETACORONAVIRUSES
Application WO-2022115486-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS VACCINES AND USES THEREOF
Application WO-2022110099-A1
World Intellectual Property Organisation (WIPO)
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2…
Grant US-11345741-B2
United States of America
Fucosylated oligosaccharides for prevention of coronavirus infection
Grant US-11331329-B2
United States of America
2'-fucosyllactose for the prevention and treatment of coronavirus-induced inflammation
Grant US-11324766-B2
United States of America
RNA INTERACTOME CAPTURING PROTOCOL AND ANTIVIRAL COMPOSITION DISCOVERED USING SAME
Application WO-2022092995-A2
World Intellectual Property Organisation (WIPO)
ANGIOTENSIN-1-7 FOR THE TREATMENT OF COVID-19
Application WO-2022094025-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS-SPECIFIC T CELL RECEPTOR FUSION CONSTRUCTS, VECTORS ENCODING THE SAME, T…
Application WO-2022084491-A1
World Intellectual Property Organisation (WIPO)
ADENOVIRUS CARRIER VACCINE USED FOR PREVENTING SARS-COV-2 INFECTION
Application EP-3804751-A4
European Patent Office
METHOD FOR DETECTING NOVEL CORONAVIRUS USING IMMUNOCHROMATOGRAPHY
Application WO-2022079755-A1
World Intellectual Property Organisation (WIPO)
DEOXYCHOLIC ACID AND ITS COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES
Application EP-3978000-A1
European Patent Office
SARS-CoV-2 NEUTRALIZING ANTIBODY OR FRAGMENT THEREOF
Application WO-2022065445-A1
World Intellectual Property Organisation (WIPO)
HIGH THROUGHPUT METHODS AND PRODUCTS FOR SARS-COV-2 SERO-NEUTRALIZATION ASSAY
Application WO-2022058621-A1
World Intellectual Property Organisation (WIPO)
NUCLEIC ACIDS ENCODING A POLYPEPTIDE COMPRISING A MODIFIED FC REGION OF A HUMAN IGG1 AND…
Application WO-2022043400-A1
World Intellectual Property Organisation (WIPO)
AMINOCARBAMOYL COMPOUNDS FOR THE TREATMENT OF VIRAL INFECTIONS
Application WO-2022043374-A1
World Intellectual Property Organisation (WIPO)
FUSION PROTEINS COMPRISING SARS-COV-2 NUCLEOCAPSID DOMAINS
Application WO-2022038499-A1
World Intellectual Property Organisation (WIPO)
SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS
Application WO-2022034221-A1
World Intellectual Property Organisation (WIPO)
COMBINATION THERAPIES FOR TREATING CORONAVIRUS INFECTION
Application WO-2022029334-A1
World Intellectual Property Organisation (WIPO)
A METHOD AND REAGENTS FOR THE DIAGNOSIS OF SARS-COV-2
Grant EP-3869199-B1
European Patent Office
RECOMBINANT VACCINIA VIRUS
Application WO-2022025298-A1
World Intellectual Property Organisation (WIPO)
INHALED INTERFERON-BETA FOR IMPROVING OUTCOME IN SARS-COV-2 INFECTED PATIENTS
Application WO-2022018422-A1
World Intellectual Property Organisation (WIPO)
NANOBODIES DIRECTED TO CORONAVIRUS SPIKE PROTEIN RECEPTOR BINDING DOMAIN AND USES THEREOF
Application WO-2022020668-A1
World Intellectual Property Organisation (WIPO)
NUCLEIC ACID LIPID PARTICLE VACCINE
Application WO-2021251453-A1
World Intellectual Property Organisation (WIPO)
A RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) VACCINE AGAINST CORONAVIRUS DISEASE
Application WO-2021250219-A1
World Intellectual Property Organisation (WIPO)
METHODS AND COMPOSITIONS FOR TREATMENT OF BRAIN VIRAL INFECTION
Application WO-2021249951-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS-BINDING AGENTS AND USES THEREOF
Application WO-2021247675-A1
World Intellectual Property Organisation (WIPO)
ANTI-VIRAL THERAPY
Application WO-2021240145-A1
World Intellectual Property Organisation (WIPO)
ISCAN: AN RT-LAMP-COUPLED CRISPR-CAS MODULE FOR RAPID, SENSITIVE DETECTION OF SARS-COV-2
Application WO-2021240443-A1
World Intellectual Property Organisation (WIPO)
FLOW DEVICE FOR DETECTION OF GLYCANS
Application WO-2021240152-A1
World Intellectual Property Organisation (WIPO)
METHOD OF DIAGNOSIS OF INFECTION BY THE SARS-COV-2 VIRUS
Application WO-2021239803-A1
World Intellectual Property Organisation (WIPO)
METHOD OF DIAGNOSIS OF INFECTION BY THE SARS-COV-2 VIRUS
Application EP-3916389-A1
European Patent Office
POLYPEPTIDES ENCODING ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN
Application WO-2021234392-A1
World Intellectual Property Organisation (WIPO)
USE OF TMPRSS2 INHIBITORS FOR THE TREATMENT OF LUNG VIRAL INFECTIONS
Application WO-2021228762-A1
World Intellectual Property Organisation (WIPO)
SINA MOLECULES, METHODS OF PRODUCTION AND USES THEREOF
Application WO-2021228585-A1
World Intellectual Property Organisation (WIPO)
SINGLE DOMAIN ANTIBODIES BINDING TO SARS-COV-2 SPIKE PROTEIN
Application WO-2021224606-A1
World Intellectual Property Organisation (WIPO)
Antibodies against SARS-CoV-2 and methods of using the same
Grant US-11168128-B2
United States of America
SINA MOLECULES, METHODS OF PRODUCTION AND USES THEREOF
Application WO-2021219708-A1
World Intellectual Property Organisation (WIPO)
COMPOSITION AND METHOD OF MRNA VACCINES AGAINST NOVEL CORONAVIRUS INFECTION
Application WO-2021159118-A3
World Intellectual Property Organisation (WIPO)
METHODS AND PRODUCTS FOR SEROLOGICAL ANALYSIS OF SARS-COV-2 INFECTION
Application WO-2021209824-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS SEROLOGY ASSAY
Application WO-2021209925-A1
World Intellectual Property Organisation (WIPO)
ANTI-SARS-COV-2 MONOCLONAL ANTIBODIES
Application WO-2021211963-A1
World Intellectual Property Organisation (WIPO)
BAT-DERIVED CORONAVIRUS VACCINE FOR PREVENTION OF COVID-19
Application WO-2021203236-A1
World Intellectual Property Organisation (WIPO)
EPITOPES HAVING SEQUENCE HOMOLOGY TO CORONAVIRUS SPIKE PROTEIN SUBUNIT AND USES THEREOF
Application EP-3892298-A1
European Patent Office
ALDOSE REDUCTASE INHIBITORS FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME…
Application WO-2021202523-A1
World Intellectual Property Organisation (WIPO)
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2…
Application WO-2021195418-A1
World Intellectual Property Organisation (WIPO)
HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-GoV-2…
Application WO-2021195385-A1
World Intellectual Property Organisation (WIPO)
DPP3 IN PATIENTS INFECTED WITH CORONAVIRUS
Application WO-2021185786-A1
World Intellectual Property Organisation (WIPO)
CORONAVIRUS ASSAY
Application WO-2021189058-A1
World Intellectual Property Organisation (WIPO)
PRO-ADRENOMEDULLIN OR FRAGMENT THEREOF IN PATIENTS INFECTED WITH CORONA VIRUS AND…
Application WO-2021185784-A1
World Intellectual Property Organisation (WIPO)
Showing items 1–100